Virtual Reality for Chronic Pain and Opioid Use Disorder Pilot

Completed · Not applicable · Has a placebo group

Conditions studied: Chronic Pain, Opioid Use Disorder

In brief

This is a pilot feasibility study of a virtual reality device for patients with co-morbid chronic pain and opioid use disorder.

Key facts

Study ID

NCT05546749

Run by

Albert Einstein College of Medicine

People needed

18

Starts

2023-02-08

Expected to finish

2023-07-12

Last updated by the study team

2025-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥18 years old
• English proficiency
• receiving methadone treatment for DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition) confirmed Opioid Use Disorder (OUD) in the Montefiore network for at least 12 weeks, with no dose change in 14 days to ensure treatment stability
• chronic pain of at least moderate pain severity (score ≥4 on the Pain, Enjoyment of Life, and General Activity (PEG) scale)
• willingness to participate in all study components
• ability to provide informed consent, assessed using consent teach-back

You may not qualify if…

• conditions that could make participation in VR hazardous or cause adverse effects (current or prior diagnosis of epilepsy, seizure disorder, dementia, or migraines, any medical condition predisposing to nausea or dizziness, hypersensitivity to flashing light or motion)
• conditions that could prevent proper use of the VR headset (stereoscopic vision or severe hearing impairment, or injury to eyes, face, or neck that prevents use of the VR headset)
• acute exacerbation of psychiatric conditions that preclude the ability to participate in the study

Where it is running

• Melrose Clinic — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.